Rockville, MD, United States of America

He Jiang

USPTO Granted Patents = 2 



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of He Jiang in HIV Research

Introduction: He Jiang, a notable inventor based in Rockville, MD, has made significant advancements in the field of HIV research through his innovative approaches to viral infection treatment. With a total of two patents under his name, Jiang's work focuses on creating modified peptide derivatives that enhance pharmacological properties and combat the effects of human immunodeficiency virus (HIV).

Latest Patents: Jiang's latest patents include a method of inhibiting HIV-1 replication by administering modified GP41 C34 peptide derivatives. This invention, which claims to address modified HIV-1 gp41 C-terminal heptad repeat fusion inhibitors, involves the preparation of peptide derivatives such as FB006M, modified with 3-maleimidoproionic acid (MPA). The innovation ensures rapid and irreversible conjugation to serum albumin, resulting in polypeptides that exhibit an extended half-life in vivo and demonstrate potent antiviral activity against HIV-1. Additionally, his patent on human immunodeficiency virus gp41 peptide derivatives emphasizes the design of inhibitors of viral infection with antifusogenic properties. These derivatives enhance the duration of action in treating both HIV and simian immunodeficiency virus (SIV).

Career Highlights: Throughout his career, He Jiang has been associated with various esteemed companies, notably Frontiers Biotechnologies Co., Ltd. Here, he contributed significantly to the development of innovative solutions aimed at combating viral infections, showcasing his expertise and dedication to enhancing public health through scientific research.

Collaborations: He Jiang has collaborated with prominent researchers in his field, including his coworker Dong Xie. Their joint efforts reflect a commitment to advancing research and developing effective treatments against HIV and related viral infections.

Conclusion: He Jiang’s contributions to HIV research through his innovative patents illustrate the impact of scientific inquiry on public health. His work not only complements existing therapies but also holds promise for significantly improving treatment outcomes for individuals affected by viral infections. The ongoing need for such innovations underscores the importance of continued research in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…